Rosa Ruchlemer

Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group

2020 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové

Publikace